ESLA
Estrella Immunopharma, Inc.
Going-concern doubt
— flagged May 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has determined that there is a substantial doubt about its ability to continue as a going concern.”View the 10-Q filed May 18, 2026
Company with tickers: ESLA, ESLAW
CIK
1844417
CUSIP
297584104
Shares Outstanding
43,034,228
Website
https://www.estrellabio.com
Investor Relations
https://www.estrellabio.com/investors
13F Activity (30d)
1 filings
1 filers
Quarterly earnings calls grouped as a single event — the transcript, the 8-K earnings release, the quarter's 10-Q or 10-K, and (where available) the audio and slide deck. Each badge shows which artefacts have landed for that quarter.
No Earnings Calls Available
No earnings call events are available for this stock yet.